Efficacy of Low-Dose Versus Traditional Buprenorphine Induction in the Hospital: A Quantitative and Qualitative Study.

"J. Bergler-Klein reports no conflicts of interest. N. Gotcheva reports no conflicts of interest. O. Kalējs reports grants and personal fees from Bayer and Boehringer Ingelheim. Z. Kalarus has lectured for Boehringer Ingelheim. D. Kovačić reports no conflicts of interest. V. Peršić reports no conflicts of interest. E. Shlyakhto reports no conflicts of interest. T. Uuetoa reports grants and personal fees from Bayer and Boehringer Ingelheim. M. V. Huisman reports grants from ZonMW Dutch Healthcare Fund, and grants and consultation honoraria from Boehringer Ingelheim, Pfizer/Bristol-Myers Squibb, Bayer Health Care, Aspen, and Daiichi-Sankyo. G. Y. H. Lip reports consultancy and speaking for BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are received personally. D. Vinereanu reports grants and personal fees from Bayer, Boehringer Ingelheim, and Pfizer."

"Supported by Boehringer Ingelheim."